Now available in the U.S., RED ™ 62 is engineered with optimized trackability to help navigate the complex distal vessel anatomy in the brain and deliver powerful aspiration for the removal of blood ...
Penumbra has issued an urgent recall of all configurations of the Penumbra JET 7 Reperfusion Catheter With Xtra Flex Technology (JET 7 Xtra Flex), owing to the risk for "unexpected death or serious ...
The new Penumbra Stroke System® (Penumbra, CA, USA) has been specifically designed for aspiration thrombectomy in the distal intracranial vasculature. The original system included two different ...
Penumbra, Inc., a global healthcare company focused on innovative therapies, today announced U.S. commercial availability of the Penumbra System's most advanced technology: Penumbra JET 7 and Penumbra ...
Amid growing interest in interventional stroke treatments, some questions have recently emerged regarding the use of various catheters for aspiration thrombectomy that aren’t approved for that purpose ...
The FDA says it received over 200 reports associated with Penumbra’s catheter, including ‘deaths, serious injuries, and malfunctions.’ Penumbra (PEN) shares slumped Wednesday after the medical device ...
ALAMEDA, Calif.--(BUSINESS WIRE)--Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced enrollment of the first patient into the CHEETAH study, a ...
In more than a dozen research papers over the past decade, an academic by the name of Dr. Antik Bose appeared to tout the reliability of catheters and other medical products made by Penumbra Inc. An ...
Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance and commercial availability of the RED ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results